Business Wire

GLOBAL-SWITCH

24.6.2020 10:02:08 CEST | Business Wire | Press release

Share
Global Switch Expands Its European Footprint as Construction Begins at its Amsterdam Data Centre Campus

Global Switch, a leading owner, operator and developer of large scale network dense, carrier and cloud neutral multi-tenanted data centres in Europe and Asia-Pacific has announced that in response to growing demand construction has started on the first stage of a new data centre in Amsterdam.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200624005069/en/

The 32,000 sq m data centre, Global Switch Amsterdam East, will be built immediately adjacent to the existing Amsterdam West facility located in the Slotervaart/Overtoomseveld district, close to the main Dutch cable infrastructure, the financial district and city centre. Global Switch Amsterdam is the only multi-tenant provider in the city with a dedicated mains supply, and once all stages of the new data centre are complete, the utility power supply capacity will increase by 40MVA, bringing the campus total to 72MVA supplied at 50kV.

In contrast to the recent moratorium on granting new data centre planning consents, importantly Global Switch Amsterdam East is a known project with Gemeente Amsterdam (City of Amsterdam) and is not impacted either by the widely announced ‘building stop’ or affected by power availability across the Metropolitan Region of Amsterdam.

Similar to other Global Switch developments, energy efficiency is at the core of the design. Amsterdam East will incorporate the latest technologies such a flooded room cooling design with hot aisle containment allowing flexible IT rack load deployment. The cooling will be generated using a free-cooling water-based cooling system and will allow the heat to be exported to the local community. The data centre will be targeting an annualised design Power Usage Effectiveness (PUE) of less than 1.2 and a BREEAM "Very Good" certification. In addition, as part of Global Switch’s comprehensive Energy Management Programme, customers will be offered 100% green energy.

John Corcoran, CEO Global Switch , said, “We are continuing to see demand for high quality, resilient and energy efficient data centres providing multiple connectivity options particularly from global hyperscale cloud providers looking for highly experienced data centre operators, such as Global Switch, as well as demand from European, US and Asian customers. We are therefore delighted to have now started construction of Global Switch Amsterdam East which will be our fourteenth data centre.”

Jasper Lankhorst, Managing Director Global Switch Amsterdam , said, “It is very exciting to be announcing this substantial addition of world class technical data centre capacity to our Amsterdam campus, particularly at a time when there is a permit stop for new data centre developments in the city and a shortage in power availability in some places of the Amsterdam Metro Area. With the acceleration of the digital economy, Global Switch Amsterdam East will provide an Open Compute Platform ready environment enabling customers to deploy at scale both with speed and cost effectively. As with all our data centres, customers will also benefit from bespoke data centre solutions, as well as a highly resilient and secure space for housing mission critical IT equipment.”

Global Switch Amsterdam West is a core node not just for the Netherlands, but also for Europe and beyond. It is one of the most connected hubs in the country and currently hosts a multitude of global and national telecommunications and cloud providers, AMS-IX and NL-IX as well as a wide range of internet services providers. With direct fibre connections between the two data centres, customers of Amsterdam East will be able to access this connectivity rich environment and will benefit from a wide choice of cloud and network providers as well as direct access to the global IP backbone. The two data centres will provide a total of four diverse entry points and four interconnected Meet Me Rooms ensuring highly resilient connections.

Peter van Burgel, CEO, AMS-IX , said, “We welcome this news by our long-term partner Global Switch. This announcement underlines the importance of the Amsterdam region as one of the largest connectivity hubs in the world and as a desirable climate for digital businesses. It also shows that the digitalisation continues to be a strong, sustainable driver for growth, even in a time when building options are challenging and the economic outlook is uncertain.”

Stijn Grove, Managing Director Dutch Data Center Association (DDA) , said, “The impact of digitalisation on our economy and society is immense. The recent events have only made people more aware that digitalisation is the sustainable way forward to grow our economy. A sound digital foundation is of crucial importance to achieve this. The Metro Region Amsterdam (MRA) is one of the key data hubs in the world and known as the Digital Gateway to Europe. Global Switch’ expansion in the MRA region will strengthen this international position as key data hub even further, and the Dutch and international economy as a whole. We are proud to have Global Switch as a member of the association and congratulate them with their expansion.”

Technical Snapshot

  • Full access to the existing network-dense, low-latency environment with a multitude of carriers and network service providers.
  • Access to peering platforms AMS-IX, NL-IX and all major cloud platforms.
  • Hyperconnected and ideally located adjacent to the main regional and international fibre routes.
  • Built in accordance to the highest operational standards with matching SLA’s.
  • Bespoke solutions with scalable space and power.
  • Open Compute Platform (OCP) facility compliance.
  • Environmentally sustainable targeting a PUE of less than 1.2.
  • Certified ISO9001, 14001, 27001, 50001, OHSAS 18001, AMS-IX, PCI-DSS, ISAE 3402 compliant.

About Global Switch

Global Switch is a leading owner, operator and developer of large-scale, carrier and cloud neutral, multi-customer data centres in Europe and Asia-Pacific. Founded in 1998, Global Switch has a proven business model, demonstrable track record and is the highest credit rated data centre company in the world with investment grade credit ratings from Fitch, Moody’s and Standard & Poor’s.

Global Switch is a vital and strategic partner for customers that require secure and resilient data centre services with scalable capacity and a high-level customer service. The Company's focus is on highly resilient, central, low latency, network dense locations in prime city centre locations and internet hubs close to its customers on the edge of financial and business districts. Global Switch’s data centres operate exclusively in the Tier I markets of Europe and Asia-Pacific to Tier III or higher and currently total around 390,000 sq m (4,200,000 sq ft) of floor space and are occupied by a broad range of customers, global and national, large and small including government organisations, financial institutions, enterprises, global systems integrators, telecommunication carriers, cloud and managed service providers and other hosting businesses.

For more information visit: www.globalswitch.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye